Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: A comparison with ciprofibrate

Thrombosis Research

Volumn 84, Issue 5, 1996, Pages 311-322

  Cignarella, Andrea ^a   Nastasi, Milena ^a   Cavalli, Elena ^a   Puglisi, Lina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

ciprofibrate; hypertriglyceridaemia; streptozotocin; Vaccinium myrtillus; venous thrombosis; Yoshida rats

Indexed keywords

CIPROFIBRATE; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; HERB; HYPERLIPIDEMIA; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VACCINIUM MYRTILLUS; VEIN THROMBOSIS;

ANIMALS; ANTHOCYANINS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CLOFIBRIC ACID; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, NONESTERIFIED; HYPERLIPIDEMIAS; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 0030561169     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(96)00195-8     Document Type: Article

References (36)

1. FROHNE, D., Heidelbeerblätter. In: Teedrogen. M.Wichtl (Ed), pp.217-219, Wissenschaftliche Verlagsgesell., Stuttgart (1990).
2. ALLEN F.M. Blueberry leaf extract: physiologic and clinical properties in relation to carbohydrate metabolism. J Am Med Ass. 89:1927;1577-1581.
3. REAVEN G.M., CHEN Y.-D.I. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev. 4:1988;639-652.
4. TASKINEN M.R., HARNO K., NIKKILÄ E.A. Serum lipids and lipoproteins in type II diabetes. Acta Endocrinol. 262((Suppl)):1984;95-99.
5. STOUT R.W. Insulin and atheroma. Diabetes care. 13:1990;631-654.
6. JUNOD A., LAMBERT A.E., ORCI L., PICTET R., GONET A.E., RENOLD A.E. Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med. 126:1967;2129-2139.
7. HEBDEN R.A., GARDINER S.M., BENNETT T., MacDONALD I.A. The influence of streptozotocin-induced diabetes mellitus on fluid and electrolyte handling in rats. Clin Sci. 70:1986;111-117.
8. ZAVARONI I., CHEN Y.-D.I., REAVEN G.M. Studies of the mechanisms of fructose-induced hypertriglyceridaemia in the rat. Metab Clin Exp. 31:1982;1077-1083.
9. THORBURN A.W., STORLIEN L.H., JENKINS A.B., KHOURI S., KRAEGEN E.W. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr. 49:1989;1155-1163.
10. BARAONA E., LIEBER C.S. Effects of ethanol on lipid metabolism. J Lipid Res. 20:1979;289-315.
11. Pathogenesis of alcohol-induced hypertriglyceridaemia. Nutr Rev 45, 215-216, 1987.
12. LIEBER C.S. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med. 319:1988;1639-1650.
13. ELKO E.E., WOOLES W.R., DI LUZIO N.R. Alterations and mobilization of lipids in acute ethanol-treated rats. Am J Physiol. 201:1961;923-926.
14. FANTAPPIÈ S., CATAPANO A.L., CANCELLIERI L., FASOLI E., DE FABIANI E., BERTOLINI M., BOSISIO E. Plasma lipoproteins and cholesterol metabolism in Yoshida rats: an animal model of spontaneous hyperlipidaemia. Life Sci. 50:1992;1913-1924.
15. PUGLISI L., CARUSO P., PINNA C., CARATOZZOLO O. Alteration of lipid metabolism potentiates experimentally-induced venous thrombosis in the rat. Thromb Haemorrh Disorders. 5:1992;51-54.
16. PUGLISI, L., CHINETTI, L. and ACCOMAZZO, M.R. The antithrombotic effect of etofibrate in the rat. In: Pharmacological control of hyperlipidaemia, pp. 327-331, J.R. Prous Science Publishers, Barcelona (1986).
17. ARNOLD A., McAULIFF J.P., POWERS L.G., PHILLIPS D.K., BEYLER A.L. The results of animal studies with ciprofibrate, a new orally effective drug. Atherosclerosis. 32:1979;155-163.
18. OLSSON A.G., ORÖ L. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinemia. Atherosclerosis. 42:1982;229-243.
19. ILLINGWORTH D.R., OLSEN G.D., COOK S.F., SEXTON G.J., WENDEL H.A., CONNOR W.E. Ciprofibrate in the therapy of type II hypercholesterolemia: a double blind trial. Atherosclerosis. 44:1982;211-221.
20. GRUNDY S.M., VEGA G.L. Fibric acids: effects on lipids and lipoprotein metabolism. Am J Med. 83:1987;9-20.
21. SIRTORI C.R., FRANCESCHINI G. Effects of fibrates on serum lipids and atherosclerosis. Pharmac Ther. 37:1988;167-191.
22. PUGLISI L., CARUSO V., CONTI R., FUMAGALLI R., SIRTORI C. Effect of hypolipidaemic and hypoglycaemic drugs on ethanol-induced hypertriglyceridaemia in rats. Pharmacol Res Comm. 9:1977;71-77.
23. NIKKILÄ E.A., OJALA K. Acute effects of fructose and glucose on the concentration and removal rates of plasma triglycerides. Life Sci. 5:1966;89-94.
24. SCHURR P.E., SCHULTZ J.E., PARKINSON T.M. Triton-induced hyperlipidaemia in rats as animal model for screening hypolipidaemic drugs. Lipids. 7:1972;68-74.
25. DAVID J.L., LEGRAND Y., CAEN J. Essai d'induction d'une thrombose expérimentale chez le lapin au moyen d'un collagène purifié C R Soc Biol. 162:1968;1763-1766.
26. LOWRY O.H., ROSEBROUGH N.J., FARR A.L., RANDALL R.J. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
27. CIGNARELLA A., BERTOZZI D., PINNA C., PUGLISI L. Hypolipidaemic activity of Vaccinium myrtillus leaves on a new model of genetically hyperlipidaemic rat. Planta Med. 58((Suppl. 1)):1992;A581-A582.
28. EDGARS N.K. A new glucoside from blueberry leaf. J Am Pharm Ass. 25:1936;288-291.
29. PETIT D., BONNEFIS M.T., REY C., INFANTE R. Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidaemic rats. Atherosclerosis. 74:1988;215-225.
30. BRUCKERT E., DEJAGER S., CHAPMAN M.J. Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidaemia. Atherosclerosis. 100:1993;91-102.
31. STEINER G., POAPST M., DAVIDSON J.K. Production of chylomicron-like lipoproteins from endogenous lipid by the intestine and liver of diabetic dogs. Diabetes. 24:1975;263-271.
32. TIENGO A., VALERIO A., MOLINARI M., MENEGHEL A., LAPOLLA A. Effect of ethanol, acetaldehyde and acetate on insulin and glucagon secretion in the perfused rat pancreas. Diabetes. 30:1981;705-709.
33. DAI S., MCNEILL J.H. Effects of fructose loading in streptozotocin-diabetic and nondiabetic rats. Can. J. Physiol. Pharmacol. 70:1992;1583-1589.
34. STRANO A., DAVÌ G., PATRONO C. In vivo platelet activation in diabetes mellitus. Semin Thromb Haemost. 17:1991;422-425.
35. SIMPSON I.A., LORIMER A.R., WALKER I.D., DAVIDSON J.F. Effect of ciprofibrate on platelet aggregation and fibrinolysis in patients with hypercholesterolemia. Thromb Haemost. 54:1985;442-444.
36. CHINELLATO A., RAGAZZI E., PETRELLI L., PARO M., MIRONOV A., ALIEV G. Effect of cholesterol-supplemented diet in heritable hyperlipidaemic Yoshida rats: functional and morphological characterization of thoracic aorta. Atherosclerosis. 106:1994;51-63.